RhumbLine Advisers’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.58M Sell
107,383
-242
-0.2% -$8.12K ﹤0.01% 1573
2025
Q4
$3.72M Sell
107,625
-17,226
-14% -$549K ﹤0.01% 1547
2025
Q3
$3.4M Sell
124,851
-6,298
-5% -$152K ﹤0.01% 1621
2025
Q2
$2.76M Buy
131,149
+6,712
+5% +$129K ﹤0.01% 1710
2025
Q1
$2.04M Buy
124,437
+10,876
+10% +$232K ﹤0.01% 1800
2024
Q4
$2.92M Buy
113,561
+585
+0.5% +$16.6K ﹤0.01% 1694
2024
Q3
$3.58M Buy
112,976
+7,179
+7% +$272K ﹤0.01% 1600
2024
Q2
$3.71M Buy
105,797
+9,387
+10% +$372K ﹤0.01% 1555
2024
Q1
$4.23M Buy
96,410
+10,444
+12% +$449K ﹤0.01% 1495
2023
Q4
$3.06M Buy
85,966
+7,172
+9% +$214K ﹤0.01% 1689
2023
Q3
$2.13M Buy
78,794
+1,812
+2% +$46K ﹤0.01% 1822
2023
Q2
$1.81M Buy
76,982
+7,771
+11% +$160K ﹤0.01% 1966
2023
Q1
$950K Buy
69,211
+5,177
+8% +$86.2K ﹤0.01% 2149
2022
Q4
$1.16M Buy
64,034
+10,356
+19% +$174K ﹤0.01% 2050
2022
Q3
$801K Buy
53,678
+3,671
+7% +$47.7K ﹤0.01% 2263
2022
Q2
$690K Buy
50,007
+10,025
+25% +$112K ﹤0.01% 2329
2022
Q1
$447K Buy
39,982
+1,835
+5% +$27K ﹤0.01% 2472
2021
Q4
$902K Buy
38,147
+2,887
+8% +$67.1K ﹤0.01% 2252
2021
Q3
$899K Buy
35,260
+5,889
+20% +$138K ﹤0.01% 2274
2021
Q2
$616K Buy
29,371
+10,763
+58% +$221K ﹤0.01% 2464
2021
Q1
$437K Buy
18,608
+1,089
+6% +$21K ﹤0.01% 2553
2020
Q4
$245K Buy
17,519
+3,849
+28% +$52.1K ﹤0.01% 2758
2020
Q3
$172K Buy
13,670
+324
+2% +$4.01K ﹤0.01% 2732
2020
Q2
$190K Buy
+13,346
New +$105K ﹤0.01% 2786

Other funds holding IDYA